These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38265425)

  • 1. Risk Factors of the Totally Implantable Venous Access Device-Related Infection in Patients With Brain Tumors Undergoing Chemotherapy After Surgery.
    Li H; Shan J
    Surg Infect (Larchmt); 2024 Mar; 25(2):133-139. PubMed ID: 38265425
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and Risk Factors for Totally Implantable Venous Access Device Infections in Pediatric Patients With Cancer: A Study of 25,954 Device-Days.
    Lee JK; Choi YB
    J Korean Med Sci; 2022 Sep; 37(35):e266. PubMed ID: 36065650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients.
    Dega H; Eliaszewicz M; Gisselbrecht M; Fleury J; Pialoux G; Janssen B; de Saint-Martin L; Gonzalez-Canali G; Dupont B
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):146-54. PubMed ID: 8862279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Totally implantable venous access device in children with cancer lead to disfiguring scar.
    Braam KI; Veening MA; Schouten-van Meeteren AY; van Dulmen-den Broeder E; Heij HA
    Pediatr Hematol Oncol; 2013 Mar; 30(2):154-64. PubMed ID: 23302017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound-based prediction of cephalic vein cutdown success prior to totally implantable venous access device placement.
    Staszewicz W; Naiken SP; Mennet A; Meyer J; Righini M; Morel P; Toso C
    J Vasc Surg Venous Lymphat Disord; 2019 Nov; 7(6):865-869.e1. PubMed ID: 31495770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.
    Amroun K; Brugel M; Rhaiem R; Teuma L; Vannieuwenhuyse G; Lipere A; Brenet E; Kianmanesh R; Bouché O
    J Vasc Access; 2024 Jan; ():11297298231223539. PubMed ID: 38205615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese expert consensus on the nursing management of the totally implantable venous access device.
    Xu Y; Fei XY; Xue YH; Wang XM; Wang XY; Zheng YT; Chen K; He JJ; Ren XH; Pan L; Wang L; Qian D; Li WF; Liang Y; Fang Y; Huang XF; Li CH; Chen DP; Wang Y; Wen LH; Zhang YH; Zheng Y; Song H; Lin YC; Zhang Q; Yang RM; Wang ZM
    J Cancer Res Ther; 2022 Sep; 18(5):1231-1240. PubMed ID: 36204867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infection of totally implantable venous access devices: A review of the literature.
    Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
    J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution.
    Choksi A; Finnegan K; Etezadi V
    Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
    Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
    World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
    Wilson GJ; van Noesel MM; Hop WC; van de Ven C
    J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of totally implantable venous access devices.
    Wang YC; Lin PL; Chou WH; Lin CP; Huang CH
    Support Care Cancer; 2017 Jul; 25(7):2049-2054. PubMed ID: 28181014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study.
    Tan L; Sun Y; Zhu L; Lei X; Liang D; Rao N; Su F; Chen K; Li S
    Cancer Manag Res; 2019; 11():8379-8389. PubMed ID: 31571994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154 Patients.
    Johnson E; Babb J; Sridhar D
    J Vasc Interv Radiol; 2016 Mar; 27(3):339-43; quiz 344. PubMed ID: 26776446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications related to totally implantable venous access devices in children and adults following lung transplantation.
    Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM
    Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial.
    Karanlik H; Kurul S; Saip P; Unal ES; Sen F; Disci R; Topuz E
    Am J Surg; 2011 Jul; 202(1):10-5. PubMed ID: 21601826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any effect of first-day usage of a totally implantable venous access device on complications?
    Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
    Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.